Quantitative in vivo imaging of tissue factor expression in glioma using dynamic contrast-enhanced MRI derived parameters.

No abstract is available for this paper.

• Publication year

  2017

• Venue

  European Journal of Radiology

• Publication date

  2017-08-01

• Fields of study

  Medicine, Engineering

• Identifiers
  DOI 10.1016/j.ejrad.2017.06.006PMID 28668420
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Tissue factor is an angiogenic-specific receptor for factor VII-targeted immunotherapy and photodynamic therapy

  2016cited by this paper
• PET Imaging of Tissue Factor in Pancreatic Cancer Using 64Cu-Labeled Active Site–Inhibited Factor VII

  2016cited by this paper
• Recombinant epidermal growth factor-like domain-1 from coagulation factor VII functionalized iron oxide nanoparticles for targeted glioma magnetic resonance imaging

  2016cited by this paper
• Early biomarkers from dynamic contrast-enhanced magnetic resonance imaging to predict the response to antiangiogenic therapy in high-grade gliomas

  2015cited by this paper
• Correlation of dynamic contrast‐enhanced MRI perfusion parameters with angiogenesis and biologic aggressiveness of rectal cancer: Preliminary results

  2015cited by this paper
• EGFP-EGF1-conjugated nanoparticles for targeting both neovascular and glioma cells in therapy of brain glioma.

  2014cited by this paper
• Prediction of methylguanine methyltransferase promoter methylation in glioblastoma using dynamic contrast-enhanced magnetic resonance and diffusion tensor imaging.

  2014cited by this paper
• Rectal cancer: Dynamic contrast‐enhanced MRI correlates with lymph node status and epidermal growth factor receptor expression

  2014cited by this paper
• The contribution of tumor and host tissue factor expression to oncogene-driven gliomagenesis.

  2014cited by this paper
• Preoperative dynamic contrast-enhanced MRI correlates with molecular markers of hypoxia and vascularity in specific areas of intratumoral microenvironment and is predictive of patient outcome.

  2014cited by this paper
• Tissue factor expression provokes escape from tumor dormancy and leads to genomic alterations

  2014cited by this paper
• Measurements of tumor vascular leakiness using DCE in brain tumors: clinical applications

  2013cited by this paper
• Quantitative analysis of neovascular permeability in glioma by dynamic contrast-enhanced MR imaging.

  2012cited by this paper
• Correlation of volume transfer coefficient Ktrans with histopathologic grades of gliomas

  2012cited by this paper
• Hypoxia triggers a proangiogenic pathway involving cancer cell microvesicles and PAR-2–mediated heparin-binding EGF signaling in endothelial cells

  2011cited by this paper
• 2-hydroxyglutarate detection by magnetic resonance spectroscopy in IDH-mutated glioma patients

  2011cited by this paper
• Tissue factor expression in ovarian cancer: implications for immunotherapy with hI-con1, a factor VII-IgGFc chimeric protein targeting tissue factor

  2011cited by this paper
• Inhibition of tissue factor/protease-activated receptor-2 signaling limits proliferation, migration and invasion of malignant glioma cells.

  2010cited by this paper
• Role of Tissue Factor in Cancer

  2009cited by this paper
• Histogram Analysis of MR Imaging–Derived Cerebral Blood Volume Maps: Combined Glioma Grading and Identification of Low-Grade Oligodendroglial Subtypes

  2008cited by this paper
• Relationship between gene expression and enhancement in glioblastoma multiforme: exploratory DNA microarray analysis.

  2008cited by this paper
• The role of tumor-and host-related tissue factor pools in oncogene-driven tumor progression.

  2007cited by this paper
• Morphology of angiogenesis in human cancer: a conceptual overview, histoprognostic perspective and significance of neoangiogenesis

  2005cited by this paper
• Signaling of the Tissue Factor Coagulation Pathway in Angiogenesis and Cancer

  2005cited by this paper
• Tumor radiosensitization by antiinflammatory drugs: evidence for a new mechanism involving the oxygen effect.

  2005cited by this paper
• Clinical application of antiangiogenic therapy: microvessel density, what it does and doesn't tell us.

  2002cited by this paper
• Tissue factor expression and angiogenesis in human glioma.

  2002cited by this paper
• Heterogeneity of angiogenesis and blood vessel maturation in human tumors: implications for antiangiogenic tumor therapies.

  2000cited by this paper

• Review of tracer kinetic models in evaluation of gliomas using dynamic contrast-enhanced imaging

  2024cites this paper
• Do coagulation or fibrinolysis reflect the disease condition in patients with soft tissue sarcoma?

  2022cites this paper
• Magnetic resonance imaging standardization for accurate grading of cerebral gliomas

  2021cites this paper
• Non-invasive monitoring of the kinetic infiltration and therapeutic efficacy of nanoparticle-labeled chimeric antigen receptor T cells in glioblastoma via 7.0-Tesla magnetic resonance imaging.

  2020cites this paper
• Is There a Direct Correlation Between Microvascular Wall Structure and k-Trans Values Obtained From Perfusion CT Measurements in Lymphomas?

  2019cites this paper
• Textural features of dynamic contrast‐enhanced MRI derived model‐free and model‐based parameter maps in glioma grading

  2018cites this paper
• Robust and efficient pharmacokinetic parameter non-linear least squares estimation for dynamic contrast enhanced MRI of the prostate.

  2018cites this paper